Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31290 | 125 | 40.5 | 90% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ZBP 89 | Author keyword | 19 | 71% | 12% | 15 |
2 | ZNF148 | Author keyword | 2 | 67% | 2% | 2 |
3 | APOPTOSIS EFFECTOR GENES | Author keyword | 1 | 50% | 1% | 1 |
4 | H4TF 1 | Author keyword | 1 | 50% | 1% | 1 |
5 | HISTONE DEACETYLASE 4 HDAC4 | Author keyword | 1 | 50% | 1% | 1 |
6 | PROXIMAL CELLS | Author keyword | 1 | 50% | 1% | 1 |
7 | REVERSIBLE ACETYLATION | Author keyword | 1 | 50% | 1% | 1 |
8 | SARCOMA REFERENCE BG UNIV HOSP BERGMANNSHEIL | Address | 1 | 50% | 1% | 1 |
9 | SCL TAL 1 GENE | Author keyword | 1 | 50% | 1% | 1 |
10 | SIR PAO CANC | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZBP 89 | 19 | 71% | 12% | 15 | Search ZBP+89 | Search ZBP+89 |
2 | ZNF148 | 2 | 67% | 2% | 2 | Search ZNF148 | Search ZNF148 |
3 | APOPTOSIS EFFECTOR GENES | 1 | 50% | 1% | 1 | Search APOPTOSIS+EFFECTOR+GENES | Search APOPTOSIS+EFFECTOR+GENES |
4 | H4TF 1 | 1 | 50% | 1% | 1 | Search H4TF+1 | Search H4TF+1 |
5 | HISTONE DEACETYLASE 4 HDAC4 | 1 | 50% | 1% | 1 | Search HISTONE+DEACETYLASE+4+HDAC4 | Search HISTONE+DEACETYLASE+4+HDAC4 |
6 | PROXIMAL CELLS | 1 | 50% | 1% | 1 | Search PROXIMAL+CELLS | Search PROXIMAL+CELLS |
7 | REVERSIBLE ACETYLATION | 1 | 50% | 1% | 1 | Search REVERSIBLE+ACETYLATION | Search REVERSIBLE+ACETYLATION |
8 | SCL TAL 1 GENE | 1 | 50% | 1% | 1 | Search SCL+TAL+1+GENE | Search SCL+TAL+1+GENE |
9 | STRESS HEMATOPOIESIS | 1 | 50% | 1% | 1 | Search STRESS+HEMATOPOIESIS | Search STRESS+HEMATOPOIESIS |
10 | ZBP | 1 | 50% | 1% | 1 | Search ZBP | Search ZBP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANSCRIPTION FACTOR ZBP 89 | 20 | 67% | 14% | 18 |
2 | ZBP 89 | 10 | 63% | 8% | 10 |
3 | NEGATIVE ELEMENT | 10 | 52% | 10% | 13 |
4 | ANTISILENCER ELEMENT | 5 | 60% | 5% | 6 |
5 | I TAX PROTEIN | 2 | 23% | 7% | 9 |
6 | VIMENTIN GENE EXPRESSION | 2 | 50% | 2% | 3 |
7 | FACTORS H4TF 1 | 1 | 33% | 2% | 2 |
8 | CELL LEUKEMIA GENE | 1 | 50% | 1% | 1 |
9 | SP1 SP3 | 1 | 50% | 1% | 1 |
10 | G RICH BOX | 1 | 29% | 2% | 2 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Transcription factor ZBP-89 in cancer growth and apoptosis | 2010 | 13 | 94 | 41% |
Regulation of epithelial cell growth by ZBP-89 - Potential relevance in pancreatic cancer | 2002 | 1 | 49 | 43% |
ZNF281/ZBP-99: a new player in epithelial-mesenchymal transition, stemness, and cancer | 2014 | 0 | 93 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SARCOMA REFERENCE BG UNIV HOSP BERGMANNSHEIL | 1 | 50% | 0.8% | 1 |
2 | SIR PAO CANC | 1 | 50% | 0.8% | 1 |
3 | RENAL UNITLEUKOCYTE BIOL INFLAMMAT PROGRAM | 0 | 33% | 0.8% | 1 |
4 | UE65 | 0 | 33% | 0.8% | 1 |
5 | GEN CATALUNYA | 0 | 17% | 0.8% | 1 |
6 | ONCOBIOL SPERIMENTALE | 0 | 17% | 0.8% | 1 |
7 | ONCOL SPERIMENTALE A | 0 | 17% | 0.8% | 1 |
8 | IMMUNOLMINATO KU | 0 | 14% | 0.8% | 1 |
9 | TUMOR GENET GRP | 0 | 14% | 0.8% | 1 |
10 | CNRS UMR 8532 | 0 | 13% | 0.8% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000139301 | PDCD4//PROGRAMMED CELL DEATH 4//PROGRAMMED CELL DEATH 4 PDCD4 |
2 | 0.0000130732 | INTERMEDIATE FILAMENTS//CYTOKERATINS//INTERMEDIATE FILAMENT |
3 | 0.0000082240 | MITHRAMYCIN//AUREOLIC ACID//TOLFENAMIC ACID |
4 | 0.0000077069 | YY1//YIN YANG 1//GON4L |
5 | 0.0000070113 | TETRAHYDROCORTISOL//OUABAIN BINDING SITE//VEKTOR STATE VIROL BIOTECHNOL |
6 | 0.0000069329 | GADD45//GADD45A//GREENSCREEN HC |
7 | 0.0000066307 | STRUCTURAL LEVELS//A STRUCTURAL PHENOMENOLOGICAL CONCEPTION//LYMPHOMA U 937 |
8 | 0.0000063971 | PU1//SPI 1 PU1//SFPI1 PU1 |
9 | 0.0000061204 | FRA 1//JUN//V JUN |
10 | 0.0000056176 | KRAB DOMAIN//KRAB//SCAN DOMAIN |